HOLX
May 1, 2023 - AI Summary
Undervalued by 34.8% based on the discounted cash flow analysis.
Market cap | $17.49 Billion |
---|---|
Enterprise Value | $17.88 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $1.92 |
Beta | 0.5 |
Outstanding Shares | 233,376,948 |
Avg 30 Day Volume | 1,398,089 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 37.5 |
---|---|
PEG | -168.57 |
Price to Sales | 4.69 |
Price to Book Ratio | 3.75 |
Enterprise Value to Revenue | 4.51 |
Enterprise Value to EBIT | 20.18 |
Enterprise Value to Net Income | 38 |
Total Debt to Enterprise | 0.14 |
Debt to Equity | 0.53 |
No data
No data
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.